|
|
News Breaks
|
November 4, 2009
|
| 14:19 EDT |  | PPHM |
| theflyonthewall.com: | Peregrine Pharmaceuticals swarded second patent for Phospholipid | | Peregrine Pharmaceuticals announced that the U.S. Patent and Trademark Office has issued U.S. Patent Number 7,611,704, which includes broad claims covering anti-viral uses of phosphatidylserine-targeting antibodies including Peregrine's lead clinical compound, bavituximab. PS is a unique marker exposed on the surface of virally infected cells that can be targeted to treat a broad spectrum of virus infections. :theflyonthewall.com |
|
|
News For PPHM From The Last 14 Days Check below for free stories on PPHM the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
January 27, 2012
|
| 10:17 EDT |  | PPHM |
|
|
|
|
|
Subscribe for More Information